Literatur
-
1
Al Nawas B, Krammer I, Shah P M.
Procalcitonin in diagnosis of severe infections.
Eur J Med Res.
1996;
1
331-333
-
2
Baue A E.
Multiple, progressive, or sequential systems failure. A syndrome of the 1970s.
Arch Surg.
1975;
110
779-781
-
3
Bone R C.
Sir Isaak Newton, sepsis, SIRS, and CARS.
Crit Care Med.
1996;
24
1125-1128
-
4
De Werra I, Jaccard C, Betz Corradin S. et al .
Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparison in patients with septic shock, cardiogenic shock, and bacterial pneumonia.
Crit Care Med.
1997;
25
607-613
-
5
Fraunberger P, Walli A K, Seidel D.
Stellenwert von Zytokinen in der Sepsis-Diagnostik.
Infusionsther Transfusionsmed.
1996;
23
(Suppl 4)
109-116
-
6
Giamarellos-Bourboulis E, Mega A, Grecka P. et al .
Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?.
Intensive Care Med.
2002;
28
1351-1356
-
7
Godin P J, Buchmann T G.
Uncoupling of biological oscillators. A complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome.
Crit Care Med.
1996;
24
1107-1116
-
8
Harbarth S, Holeckova K, Froidevaux C. et al .
Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis.
Am J Respir Crit Care Med.
2001;
164
396-402
-
9
Members of the American College of Chest Physician/Society of Critical Care Medicine Consensus Conference Committee .
Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.
Crit Care Med.
1992;
20
864-874
-
10
Müller-Werdan U, Prondzinsky R, Witthaut R, Stache N, Heinroth K, Kuhn C, Schmidt H, Busch I, Werdan K.
Das Herz bei Sepsis und MODS.
Wien Klin Wochenschr.
1997;
109
(Suppl 1)
3-24
-
11
Panacek E A, Marshall J, Fischkoff S. et al .
Neutralization of TNF by a monoclonal antibody improves survival and reduces organ dysfunction in human sepsis: Results of the MONARCS trial.
Chest.
2000;
118
885
-
12
Pilz G, Fraunberger P, Appel R, Kreuzer E, Werdan K, Walli A, Seidel D.
Bedeutung erhöhter TNF-Rezeptorspiegel bei herzchirurgischen Risikopatienten.
Infusionsther Transfusionsmed.
1996;
23
(Suppl 4)
29-34
-
13
Pilz G, Fraunberger P, Appel R, Kreuzer E, Werdan K, Walli A, Seidel D.
Early prediction of outcome in score-identified, postcardiac patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations.
Crit Care Med.
1996;
24
596-600
-
14
Pilz G, Werdan K.
Scores für Multiorgandysfunktion und Multiorganversagen.
Internist.
1998;
39
502-508
-
15
Reinhart K, Meisner M, Hartog C.
Diagnosis of sepsis: Novel and conventional parameters.
Advances in Sepsis.
2001;
1
42-51
-
16
Reinke P, Döcke W -D, Kox W. et al .
Neue Entwicklungen in der Immundiagnostik intensivmedizinischer Patienten.
Dtsch Med Wochenschr.
1999;
124
1527-1529
-
17
Vincent J -L, Moreno R, Takala J. et al .
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure.
Intensive Care Med.
1996;
22
707-710
-
18
Vincent J -L.
Dear SIRS, I’m sorry to say that I don’t like you.
Crit Care Med.
1997;
25
372-274
-
19 Werdan K, Müller-Werdan U. Sektion VI. Schock. 5. vollk. überarb. Auflage Springer-Verlag Heidelberg New York In: Erdmann E (Hrsg) Klinische Kardiologie 2000: 703-796
-
20
Winchell R J, Hoyt D B.
Spectral analysis of heart rate variability in the ICU.
J Surg Res.
1996;
63
11-16
-
21
Witthaut R, Werdan K, Schuster H -P.
Multiorgandysfunktions-Syndrom und Multiorganversagen - Diagnose, Prognose und Therapiekonzepte.
Internist.
1998;
39
493-501
-
22
Witthaut R, Werdan K.
Ergebnisforschung am Beispiel der Sepsis.
Internist.
1996;
37
1249-1259
Priv.-Doz. Dr. med. Ursula Müller-Werdan
Universitätsklinik und Poliklinik für Innere Medizin III, Universität Halle-Wittenberg
Ernst-Grube-Straße 40
06097 Halle
Phone: 0345/5572816, -2601
Fax: 0345/5572072
Email: ursula.mueller-werdan@medizin.uni-halle.de
